Sale!

Rx Simparica Trio Chewable Tablets for Dogs

Original price was: $169.04.Current price is: $35.65.

SKU: maviprbn14358 Category:

Description

Rx Simparica Trio Chewable Tablets

Simparica Trio is a monthly chewable treatment for dogs that provides triple protection against heartworms, ticks, fleas, roundworms, and hookworms. Starting to kill fleas in just four hours, it is also safe for puppies from eight weeks of age, offering complete protection in one convenient dose.

Why Choose Simparica Trio for Your Dog?

Simparica Trio is the ideal solution for comprehensive parasite protection. This monthly chewable treatment not only combats fleas and ticks, but also protects against intestinal worms and heartworm disease. With triple coverage, it ensures that your dog stays safe, healthy, and free from parasites.

Complete Protection in One Dose

Simparica Trio contains three active ingredients—sarolaner, moxidectin, and pyrantel—that provide complete protection. Whether it’s fleas, ticks, hookworms, or heartworm prevention, this all-in-one solution ensures your dog is protected with just one monthly dose.

Fast and Effective

Simparica Trio begins killing fleas within four hours and continues to act as a persistent repellent against ticks and fleas. This quick and effective action ensures that your dog stays comfortable and parasite-free in no time.

Safe for Puppies

Simparica Trio is safe for puppies as young as eight weeks old and weighing at least 2.8 pounds, making it an excellent choice for starting your dog’s parasite protection early.

Conclusion

With Simparica Trio, you’re choosing a reliable and proven solution for keeping your dog protected from parasites. Easy to administer and highly effective, Simparica Trio offers peace of mind for a healthier, happier pet.

This product requires a Valid prescription.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Reviews

There are no reviews yet.

Be the first to review “Rx Simparica Trio Chewable Tablets for Dogs”

Your email address will not be published. Required fields are marked *